SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Anthem, Inc. – ‘10-Q’ for 9/30/20

On:  Wednesday, 10/28/20, at 4:02pm ET   ·   For:  9/30/20   ·   Accession #:  1156039-20-89   ·   File #:  1-16751

Previous ‘10-Q’:  ‘10-Q’ on 7/29/20 for 6/30/20   ·   Next:  ‘10-Q’ on 4/21/21 for 3/31/21   ·   Latest:  ‘10-Q’ on 4/18/24 for 3/31/24   ·   11 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

10/28/20  Anthem, Inc.                      10-Q        9/30/20   97:14M

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.63M 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     32K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     32K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     28K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     28K 
12: R1          Document And Entity Information Document            HTML     80K 
13: R2          Consolidated Balance Sheets                         HTML    120K 
14: R3          Consolidated Balance Sheets (Parenthetical)         HTML     52K 
15: R4          Consolidated Statements Of Income                   HTML     93K 
16: R5          Consolidated Statements of Comprehensive Income     HTML     52K 
17: R6          Consolidated Statements Of Cash Flows               HTML    122K 
18: R7          Consolidated Statements Of Shareholders' Equity     HTML     99K 
19: R8          Organization                                        HTML     32K 
20: R9          Basis Of Presentation and Significant Accounting    HTML     60K 
                Policies                                                         
21: R10         Business Acquisitions                               HTML     32K 
22: R11         Business Optimization Initiatives                   HTML     30K 
23: R12         Investments                                         HTML    235K 
24: R13         Derivative Financial Instruments Derivative         HTML     31K 
                Financial Instruments                                            
25: R14         Fair Value                                          HTML    281K 
26: R15         Income Taxes                                        HTML     31K 
27: R16         Retirement Benefits                                 HTML     65K 
28: R17         Medical Claims Payable                              HTML    136K 
29: R18         Debt                                                HTML     42K 
30: R19         Commitments And Contingencies                       HTML     63K 
31: R20         Capital Stock                                       HTML     85K 
32: R21         Accumulated Other Comprehensive Income              HTML     83K 
33: R22         Earnings Per Share                                  HTML     39K 
34: R23         Segment Information                                 HTML    142K 
35: R24         Leases                                              HTML     65K 
36: R25         Basis of Presentation and Significant Accounting    HTML     76K 
                Policies (Policies)                                              
37: R26         Investments (Tables)                                HTML    241K 
38: R27         Fair Value (Tables)                                 HTML    267K 
39: R28         Retirement Benefits (Tables)                        HTML     65K 
40: R29         Medical Claims Payable (Tables)                     HTML    136K 
41: R30         Debt (Tables)                                       HTML     33K 
42: R31         Capital Stock (Tables)                              HTML     92K 
43: R32         Accumulated Other Comprehensive Income (Tables)     HTML     85K 
44: R33         Earnings Per Share (Tables)                         HTML     38K 
45: R34         Segment Information (Tables)                        HTML    144K 
46: R35         Leases (Tables)                                     HTML     67K 
47: R36         Organization (Details)                              HTML     32K 
48: R37         Basis of Presentation and Signficant Accounting     HTML     42K 
                Policies Basis of Presentation and Significant                   
                Acconting Policies (Details)                                     
49: R38         Business Acquisitions Business Acquisition (Assets  HTML     47K 
                Liabilities Acquired) (Details)                                  
50: R39         Business Optimization Initiatives Narrative         HTML     45K 
                (Details)                                                        
51: R40         Investments (Current And Long-Term Fixed Maturity   HTML     92K 
                Securities, Available-For-Sale) (Details)                        
52: R41         Investments (Aggregate Fair Value And Gross         HTML     76K 
                Unrealized Loss Of Fixed Maturity Securities In An               
                Unrealized Loss Position) (Details)                              
53: R42         Investments (Allowance For Credit Loss              HTML     46K 
                Rollforward) (Details)                                           
54: R43         Investments (Amortized Cost And Fair Value Of       HTML     59K 
                Fixed Maturity Securities, By Contractual                        
                Maturity) (Details)                                              
55: R44         Investments (Proceeds and Realized Gains Losses     HTML     34K 
                From Fixed Maturity Securities) (Details)                        
56: R45         Investments (Current and Long-term Equity           HTML     37K 
                Securities) (Details)                                            
57: R46         Investments (Gains and Losses Recognized on Equity  HTML     35K 
                Securities) (Details)                                            
58: R47         Investments (Securities Lending Programs)           HTML     40K 
                (Details)                                                        
59: R48         Investments (Narrative) (Details)                   HTML     34K 
60: R49         Derivative Financial Instruments (Financial         HTML     32K 
                Statement Narrative) (Details)                                   
61: R50         Fair Value (Fair Value Measurements By Level For    HTML    147K 
                Assets Measured At Fair Value On A Recurring                     
                Basis) (Details)                                                 
62: R51         Fair Value (Reconciliation Of The Beginning And     HTML     77K 
                Ending Balances Of Assets Measured At Fair Value                 
                On A Recurring Basis Using Level III Inputs)                     
                (Details)                                                        
63: R52         Fair Value (Carrying And Estimated Fair Values by   HTML     55K 
                Level Of Financial Instruments Not Recorded At                   
                Fair Value On Consolidated Balance Sheet)                        
                (Details)                                                        
64: R53         Income Taxes (Narrative) (Details)                  HTML     35K 
65: R54         Retirement Benefits (Components Of Net Periodic     HTML     53K 
                (Benefit Credit) Benefit Cost) (Details)                         
66: R55         Retirement Benefits (Narrative) (Details)           HTML     28K 
67: R56         Medical Claims Payable (Reconciliation Of The       HTML     88K 
                Beginning And Ending Balances For Medical Claims                 
                Payable By Segment) (Details)                                    
68: R57         Medical Claims Payable (Reconciliation Of Net       HTML     44K 
                Incurred Medical Claims To Benefit Expense)                      
                (Details)                                                        
69: R58         Medical Claims Payable Medical Claims Payable       HTML     50K 
                (Reconciliation of the Claims Development to the                 
                Claims Liability) (Details)                                      
70: R59         Medical Claims Payable (Narrative) (Details)        HTML     46K 
71: R60         Debt (Convertible Debenture Details) (Details)      HTML     44K 
72: R61         Debt (Narrative) (Details)                          HTML    106K 
73: R62         Commitments And Contingencies (Details)             HTML     56K 
74: R63         Capital Stock (Summary of Cash Dividend Activity)   HTML     38K 
                (Details)                                                        
75: R64         Capital Stock (Summary of Share Repurchases)        HTML     38K 
                (Details)                                                        
76: R65         Capital Stock (Summary of Stock Option Activity)    HTML     64K 
                (Details)                                                        
77: R66         Capital Stock (Nonvested Restricted Stock Activity  HTML     52K 
                Including Restricted Stock Units) (Details)                      
78: R67         Capital Stock (Fair Values of Options Granted       HTML     37K 
                During The Period Estimated Using Weighted-Average               
                Assumptions) (Details)                                           
79: R68         Capital Stock (Schedule Of Weighted-Average Fair    HTML     32K 
                Values Determined For The Periods) (Details)                     
80: R69         Capital Stock (Narrative) (Details)                 HTML     50K 
81: R70         Accumulated Other Comprehensive Loss                HTML     79K 
                (Reconciliation Of The Components Of Accumulated                 
                Other Comprehensive Income) (Details)                            
82: R71         Accumulated Other Comprehensive Income (Other       HTML     50K 
                Comprehensive Income (Loss) Reclassification                     
                Adjustments) (Details)                                           
83: R72         Accumulated Other Comprehensive Income (Loss)       HTML     46K 
                Accumulated Other Comprehensive Income                           
                Reclassification Adjustments (Details)                           
84: R73         Earnings Per Share (Denominator For Basic And       HTML     34K 
                Diluted Earnings Per Share) (Details)                            
85: R74         Earnings Per Share (Narrative) (Details)            HTML     34K 
86: R75         Segment Information (Financial Data By Reportable   HTML     62K 
                Segment) (Details)                                               
87: R76         Segment Information Segment Information (Major      HTML     56K 
                Product Revenues for Each Reportable Segment)                    
                (Details)                                                        
88: R77         Segment Information (Reconciliation Of Reportable   HTML     38K 
                Segments Operating Revenues To Total Revenues                    
                Reported In The Consolidated Statements Of Income)               
                (Details)                                                        
89: R78         Segment Information (Reconciliation Of Reportable   HTML     46K 
                Segments Operating Gain To Income Before Income                  
                Tax Expense Included In The Consolidated                         
                Statements Of Income) (Details)                                  
90: R79         Segment Information Segment Information             HTML     28K 
                (Narrative) (Details)                                            
91: R80         Leases (Lease and Other Information) (Details)      HTML     51K 
92: R81         Leases (Reconciliation of Future Lease Payments to  HTML     46K 
                Total Lease Liabilities) (Details)                               
93: R82         Leases (Narrative) (Details)                        HTML     48K 
95: XML         IDEA XML File -- Filing Summary                      XML    187K 
11: XML         XBRL Instance -- antm-20200930_htm                   XML   4.52M 
94: EXCEL       IDEA Workbook of Financial Reports                  XLSX    144K 
 7: EX-101.CAL  XBRL Calculations -- antm-20200930_cal               XML    279K 
 8: EX-101.DEF  XBRL Definitions -- antm-20200930_def                XML   1.17M 
 9: EX-101.LAB  XBRL Labels -- antm-20200930_lab                     XML   2.52M 
10: EX-101.PRE  XBRL Presentations -- antm-20200930_pre              XML   1.59M 
 6: EX-101.SCH  XBRL Schema -- antm-20200930                         XSD    250K 
96: JSON        XBRL Instance as JSON Data -- MetaLinks              503±   809K 
97: ZIP         XBRL Zipped Folder -- 0001156039-20-000089-xbrl      Zip    480K 




        
Filing Submission 0001156039-20-000089 – SGML Text

Original SGML Text submitted by:  Elevance Health, Inc. [ formerly Anthem, Inc. ]

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 6:25:42.3pm ET